These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19862502)

  • 21. Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.
    Watanabe J; Nishiyama H; Okubo K; Takahashi T; Toda Y; Habuchi T; Kakehi Y; Tada M; Ogawa O
    Urology; 2004 May; 63(5):989-93. PubMed ID: 15135005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of heavy metal toxicity in eukaryotes using a simple functional assay.
    Riger CJ; Fernandes PN; Vilela LF; Mielniczki-Pereira AA; Bonatto D; Henriques JA; Eleutherio EC
    Metallomics; 2011 Dec; 3(12):1355-61. PubMed ID: 21879111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts.
    Fronza G; Inga A; Monti P; Scott G; Campomenosi P; Menichini P; Ottaggio L; Viaggi S; Burns PA; Gold B; Abbondandolo A
    Mutat Res; 2000 Apr; 462(2-3):293-301. PubMed ID: 10767639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in XPD and TP53 and mutation in human lung cancer.
    Mechanic LE; Marrogi AJ; Welsh JA; Bowman ED; Khan MA; Enewold L; Zheng YL; Chanock S; Shields PG; Harris CC
    Carcinogenesis; 2005 Mar; 26(3):597-604. PubMed ID: 15564288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Peng J; Tang G; Goswami M; Young KH; Singh R; Medeiros LJ; Kantarjian HM; Luthra R; Wang SA
    J Hematol Oncol; 2015 May; 8():45. PubMed ID: 25952993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast.
    Smardová J; Pavlová S; Koukalová H
    Pathol Oncol Res; 2002; 8(4):245-51. PubMed ID: 12579210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a transcriptionally inactive p53 mutant by functional analysis of separated alleles in yeasts (FASAY) in a child osteosarcoma tumor: a case report.
    Dekairelle AF; Brichard B; Delhez H; Gala JL
    Pediatr Hematol Oncol; 2004 Jun; 21(4):321-8. PubMed ID: 15205094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant frequency and mutational spectra in the Tk and Hprt genes of N-ethyl-N-nitrosourea-treated mouse lymphoma cellsdagger.
    Chen T; Harrington-Brock K; Moore MM
    Environ Mol Mutagen; 2002; 39(4):296-305. PubMed ID: 12112381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
    Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
    J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous and ethylnitrosourea-induced mutation fixation and molecular spectra at the lacI transgene in the Big Blue rat-2 embryo cell line.
    Zimmer DM; Zhang XB; Harbach PR; Mayo JK; Aaron CS
    Environ Mol Mutagen; 1996; 28(4):325-33. PubMed ID: 8991060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF; Weissler MC; Pei H; Conway K
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.
    Tada M; Iggo RD; Ishii N; Shinohe Y; Sakuma S; Estreicher A; Sawamura Y; Abe H
    Int J Cancer; 1996 Jul; 67(3):447-50. PubMed ID: 8707423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder.
    Dekairelle AF; Tombal B; Cosyns JP; Gala JL
    Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of TP53 gene mutations in sinonasal cancer.
    Holmila R; Bornholdt J; Suitiala T; Cyr D; Dictor M; Steiniche T; Wolff H; Wallin H; Luce D; Husgafvel-Pursiainen K
    Mutat Res; 2010 Apr; 686(1-2):9-14. PubMed ID: 20025891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology.
    Inga A; Iannone R; Monti P; Molina F; Bolognesi M; Abbondandolo A; Iggo R; Fronza G
    Oncogene; 1997 Mar; 14(11):1307-13. PubMed ID: 9178891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.